Kathleen Mullin

2PUBLICATIONS
1CO-AUTHORS
Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 30, 2024
Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study.

Kathleen Mullin, Robert Croop, Linda Mosher

|Jul 03, 2024
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks.

Richard B Lipton, Jessica Ailani, Kathleen Mullin

Pageof 1

Frequent Collaborators